Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

ACE vs ARB

Andrew Buelt, DO
00:00
10:08
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Andrew Buelt has often wondered why clinicians are so quick to prescribe ACE inhibitors over ARBs. In this segment, he looks at the literature to investigate whether or not this is actual best practice.

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

Anastasia P. -

Great podcast. Would be interested to hear your comments and review on this article that argues further for ARB

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4209 (Published 24 October 2018)
Cite this as: BMJ 2018;363:k4209

Anastasia

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Clots and OCP's Full episode audio for MD edition 177:43 min - 83 MB - M4APrimary Care RAP December 2018 Written Summary 520 KB - PDF

To earn CME for this chapter, you need to subscribe.

Sign up today for full access to all episodes and earn CME.

0.25 Free AMA PRA Category 1 Credits™ certified by Hippo Education or 0.25 Free prescribed credits by the American Academy of Family Physicians

  1. Complete Quiz
  2. Complete Evaluation
  3. Print Certificate

3.25 AMA PRA Category 1 Credits™ certified by Hippo Education or 3.25 prescribed credits by the American Academy of Family Physicians

  1. Complete Quiz
  2. Complete Evaluation
  3. Print Certificate